Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ)
CNY 5.88
(3.34%)
CNY 5.88
(3.34%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 171.79 Million CNY | 6.84% |
| 2022 | 160.79 Million CNY | -2.63% |
| 2021 | 165.13 Million CNY | -13.78% |
| 2020 | 191.53 Million CNY | 0.81% |
| 2019 | 190 Million CNY | 9.61% |
| 2018 | 173.35 Million CNY | -4.63% |
| 2017 | 181.77 Million CNY | 4.89% |
| 2016 | 173.29 Million CNY | -3.14% |
| 2015 | 178.92 Million CNY | 65.17% |
| 2014 | 108.32 Million CNY | 7.56% |
| 2013 | 100.71 Million CNY | 111.58% |
| 2012 | 47.59 Million CNY | 15.47% |
| 2011 | 41.22 Million CNY | -30.24% |
| 2010 | 59.09 Million CNY | 83.27% |
| 2009 | 32.24 Million CNY | -0.41% |
| 2008 | 32.37 Million CNY | 36.81% |
| 2007 | 23.66 Million CNY | 188.35% |
| 2006 | 8.2 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 159.19 Million CNY | -7.33% |
| 2024 Q3 | 188.4 Million CNY | 24.18% |
| 2024 Q2 | 151.71 Million CNY | -4.7% |
| 2023 FY | 171.79 Million CNY | 6.84% |
| 2023 Q1 | 156.64 Million CNY | -2.59% |
| 2023 Q4 | 171.79 Million CNY | 3.5% |
| 2023 Q3 | 165.97 Million CNY | 8.93% |
| 2023 Q2 | 152.37 Million CNY | -2.73% |
| 2022 Q2 | 157.39 Million CNY | -4.4% |
| 2022 Q3 | 161.25 Million CNY | 2.46% |
| 2022 Q4 | 160.79 Million CNY | -0.28% |
| 2022 Q1 | 164.64 Million CNY | -0.3% |
| 2022 FY | 160.79 Million CNY | -2.63% |
| 2021 FY | 165.13 Million CNY | -13.78% |
| 2021 Q2 | 196.82 Million CNY | 18.69% |
| 2021 Q3 | 192.53 Million CNY | -2.18% |
| 2021 Q4 | 165.13 Million CNY | -14.23% |
| 2021 Q1 | 165.83 Million CNY | -13.42% |
| 2020 Q3 | 197.09 Million CNY | -0.37% |
| 2020 Q1 | 177.09 Million CNY | -6.8% |
| 2020 Q4 | 191.53 Million CNY | -2.82% |
| 2020 FY | 191.53 Million CNY | 0.81% |
| 2020 Q2 | 197.81 Million CNY | 11.7% |
| 2019 FY | 190 Million CNY | 9.61% |
| 2019 Q1 | 164.93 Million CNY | -4.86% |
| 2019 Q4 | 190 Million CNY | 7.26% |
| 2019 Q3 | 177.15 Million CNY | 8.33% |
| 2019 Q2 | 163.53 Million CNY | -0.85% |
| 2018 Q2 | 150.23 Million CNY | 1.28% |
| 2018 Q3 | 172.02 Million CNY | 14.5% |
| 2018 FY | 173.35 Million CNY | -4.63% |
| 2018 Q4 | 173.35 Million CNY | 0.77% |
| 2018 Q1 | 148.33 Million CNY | -18.39% |
| 2017 Q4 | 181.77 Million CNY | 23.52% |
| 2017 FY | 181.77 Million CNY | 4.89% |
| 2017 Q3 | 147.15 Million CNY | 17.43% |
| 2017 Q2 | 125.32 Million CNY | -7.34% |
| 2017 Q1 | 135.24 Million CNY | -21.96% |
| 2016 FY | 173.29 Million CNY | -3.14% |
| 2016 Q3 | 134.42 Million CNY | 8.75% |
| 2016 Q2 | 123.6 Million CNY | -9.07% |
| 2016 Q1 | 135.93 Million CNY | -24.03% |
| 2016 Q4 | 173.29 Million CNY | 28.92% |
| 2015 FY | 178.92 Million CNY | 65.17% |
| 2015 Q1 | 107.11 Million CNY | -1.11% |
| 2015 Q4 | 178.92 Million CNY | 19.68% |
| 2015 Q3 | 149.49 Million CNY | 9.99% |
| 2015 Q2 | 135.91 Million CNY | 26.88% |
| 2014 Q3 | 88.92 Million CNY | 6.82% |
| 2014 Q2 | 83.24 Million CNY | 5.6% |
| 2014 FY | 108.32 Million CNY | 7.56% |
| 2014 Q1 | 78.83 Million CNY | -21.72% |
| 2014 Q4 | 108.32 Million CNY | 21.82% |
| 2013 Q2 | 45.36 Million CNY | -7.97% |
| 2013 Q4 | 100.71 Million CNY | 102.76% |
| 2013 FY | 100.71 Million CNY | 111.58% |
| 2013 Q1 | 49.29 Million CNY | 3.57% |
| 2013 Q3 | 49.67 Million CNY | 9.48% |
| 2012 Q3 | 38.79 Million CNY | 26.2% |
| 2012 Q2 | 30.73 Million CNY | -19.33% |
| 2012 Q4 | 47.59 Million CNY | 22.71% |
| 2012 FY | 47.59 Million CNY | 15.47% |
| 2012 Q1 | 38.1 Million CNY | -7.56% |
| 2011 FY | 41.22 Million CNY | -30.24% |
| 2011 Q4 | 41.22 Million CNY | 6.63% |
| 2011 Q3 | 38.65 Million CNY | -17.09% |
| 2011 Q1 | 52.9 Million CNY | -10.47% |
| 2011 Q2 | 46.62 Million CNY | -11.87% |
| 2010 Q4 | 59.09 Million CNY | 5.84% |
| 2010 Q1 | 30.7 Million CNY | -4.78% |
| 2010 Q2 | 45.19 Million CNY | 47.21% |
| 2010 Q3 | 55.82 Million CNY | 23.52% |
| 2010 FY | 59.09 Million CNY | 83.27% |
| 2009 FY | 32.24 Million CNY | -0.41% |
| 2009 Q4 | 32.24 Million CNY | 13.12% |
| 2009 Q3 | 28.5 Million CNY | -5.46% |
| 2009 Q2 | 30.15 Million CNY | 0.0% |
| 2008 FY | 32.37 Million CNY | 36.81% |
| 2008 Q4 | 32.37 Million CNY | 0.0% |
| 2007 FY | 23.66 Million CNY | 188.35% |
| 2006 FY | 8.2 Million CNY | 0.0% |